Genespire

Genespire company information, Employees & Contact Information

Explore related pages

Related company profiles:

Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases. Based in Milan, Italy, Genespire was founded in March 2020 by the gene therapy pioneer Prof. Luigi Naldini, Dr. Alessio Cantore, Fondazione Telethon and Ospedale San Raffaele. It is a spin-off of SR-Tiget, a world leading cell and gene therapy research institute and is backed by Sofinnova Partners.

Company Details

Employees
14
Founded
-
Address
Via Vincenzo Gioberti, 8,italy
Phone
39 02 83991300
Email
in****@****ire.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Milan, Lombardy
Looking for a particular Genespire employee's phone or email?

Genespire Questions

News

Genespire announces oral presentation at the ASGCT Annual Meeting detailing preclinical insights into dosing for first-in-human in vivo liver-directed ISLV gene therapy for MMA - Yahoo Finance

Genespire announces oral presentation at the ASGCT Annual Meeting detailing preclinical insights into dosing for first-in-human in vivo liver-directed ISLV gene therapy for MMA Yahoo Finance

Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting - GlobeNewswire

Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting GlobeNewswire

Genespire raises $52m in Series B to trial paediatric gene therapy - Pharmaceutical Technology

Genespire raises $52m in Series B to trial paediatric gene therapy Pharmaceutical Technology

An Italian biotech gets $52M to advance pediatric gene therapies - BioPharma Dive

An Italian biotech gets $52M to advance pediatric gene therapies BioPharma Dive

Genespire raises US$52m in Series B round - European Biotechnology Magazine

Genespire raises US$52m in Series B round European Biotechnology Magazine

Genespire raises €46.6 million (~$52 million) in a Series B - GlobeNewswire

Genespire raises €46.6 million (~$52 million) in a Series B GlobeNewswire

Genespire Presents Promising Preclinical Data on Liver-Directed Gene Therapy for MMA at ASGCT 2025 - geneonline.com

Genespire Presents Promising Preclinical Data on Liver-Directed Gene Therapy for MMA at ASGCT 2025 geneonline.com

Genespire raises €47M to advance Gene-202, lentiviral vectors - BioWorld MedTech

Genespire raises €47M to advance Gene-202, lentiviral vectors BioWorld MedTech

Genespire appoints Karen Aiach-Pignet as Chief Executive Officer - GlobeNewswire

Genespire appoints Karen Aiach-Pignet as Chief Executive Officer GlobeNewswire

Top Genespire Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant